BofA Finance LLC has announced the launch of its Contingent Income Auto-Callable Yield Notes, with a total offering of $753,000. This move is significant for the company as it expands its product offerings and taps into the performance of major technology stocks.
The notes are linked to the least performing stocks of Alphabet Inc., Meta Platforms, Inc., and Amazon.com, Inc., reflecting a strategic positioning in the market. The issuance of these notes indicates BofA Finance's commitment to providing innovative financial solutions that align with current market trends.
Background
BofA Finance LLC operates under the SIC code 6021, classified as a national commercial bank. The company is incorporated in Delaware and has its headquarters in Charlotte, North Carolina. BofA Finance is a subsidiary of Bank of America Corporation, which is also a national commercial bank.
Recent filings show that BofA Finance LLC submitted multiple forms on November 4, 2026, with the most notable being the 424B2 registration statement for the Yield Notes.
What the Filing Says
The filing states, "Contingent Income Auto-Callable Yield Notes Linked to the Least Performing of the Class A Common Stock of Alphabet Inc., the Class A Common Stock of Meta Platforms, Inc. and the Common Stock of Amazon.com, Inc." The notes are set to issue on November 5, 2026, and will have a term of approximately five years if not called prior to maturity.
Impact
This offering may affect investors looking for innovative products in the national commercial banking sector. The notes carry a contingent coupon rate of 8.10% per annum, which could attract those interested in higher yield investments. Additionally, the performance of the underlying stocks will be crucial in determining the returns for investors.
What's Next
Details were not available in the SEC filing regarding further actions or upcoming filings related to this offering. Investors and stakeholders will likely be monitoring the performance of the notes and the underlying stocks closely.
Read Next
POMDOCTOR Ltd Converts Debt to Equity in Major Agreement
Quoin Pharmaceuticals Enters Sales Agreement with Leerink
AT Umbrella LLC files new private offering of $1.92 billion
Summit Therapeutics registers 108.96 million shares for resale
GS Finance Corp. unveils new market-linked securities offering
Live Oak Bancshares announces public offering of preferred stock








